Issue 1/2023
Content (7 Articles)
Orexin Receptor Antagonists in the Treatment of Depression: A Leading Article Summarising Pre-clinical and Clinical Studies
Harry Fagan, Edward Jones, David S. Baldwin
Treatment Outcomes of Newly Diagnosed Epilepsy: A Systematic Review and Meta-analysis
Mubeen Janmohamed, Haris Hakeem, Suyi Ooi, Suhailah Hakami, Lily Vu, Piero Perucca, Terence J. O’Brien, Ana Antonic-Baker, Zhibin Chen, Patrick Kwan
Early Morning ADHD Symptoms and Functional Impairment: Impact on Patients and Caregivers, and Pharmacological Approaches to Management
Ann C. Childress, Kenisha R. Yu, Lewis Cuthbertson
Leveraging Molecular and Immune-Based Therapies in Leptomeningeal Metastases
Jessica A. Wilcox, Adrienne A. Boire
Treatment of Patients with Multiple Sclerosis Transitioning Between Relapsing and Progressive Disease
Nikolaos G. Dimitriou, Sven G. Meuth, Elena H. Martinez-Lapiscina, Philipp Albrecht, Til Menge
Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder
Dieter Kunz, Yves Dauvilliers, Heike Benes, Diego García-Borreguero, Giuseppe Plazzi, Dalma Seboek Kinter, Preciosa Coloma, Magdalene Rausch, Mouna Sassi-Sayadi, Stephen Thein
A 10-Year Observational Study of the Use, Acceptability and Effectiveness of Long-Acting Paliperidone Palmitate: Implications for Clinical Decision Making
Sofia Pappa, Joshua Barnett, Katy Mason